Navigation Links
Breakthrough AffloVest now reimbursed by Medicare and private health insurance
Date:9/10/2013

AUSTIN, Texas, Sept. 10, 2013 /PRNewswire/ -- AffloVest, the first-ever portable High Frequency Chest Wall Oscillation (HFCWO) vest, is now approved for Medicare and private health insurance reimbursement.  Millions of Americans with respiratory disease can benefit from the innovative new airway clearance therapy vest that dramatically improves cough productivity and ease of breathing for chronic lung conditions such as severe Chronic Obstructive Pulmonary Disease (COPD), Chronic Bronchitis, Cystic Fibrosis and other related ailments.

The AffloVest recently earned FDA 510k market clearance in the United States and HCPCS reimbursement codes, according to David Shockley, President of International Biophysics Corporation (IBC), which developed and now markets the product in the U.S.

"With both Medicare and private health insurance reimbursement approved for AffloVest, this breakthrough technology is affordably available to millions of patients now," Shockley said.  "Other airway clearance vests tether the patient by an air hose to bulky machines that must be plugged into a wall.  The AffloVest is the market's first portable, battery-operated HFCWO vest. Users can move about freely – even travel – during treatments, or sit comfortably in any position, even while lying down," Shockley said. 

A recent clinical study — conducted by Dr. Konrad Schultz at the Bad Reichenhall Clinic in Munich, Germany — reveals that AffloVest substantially improves cough productivity, making it easier for patients to clear their lungs and breathe more easily through a productive cough.
The study concluded: 

"With every single patient, a dramatic improvement in cough productivity and bronchial secretion viscosity was observed in combination with the pulmonary and orthopedic regimen of care. It became fundamentally easier for the patients to cough out mucus, because of the more fluid secretions and more productive cough provided by the introduction of High Frequency Chest Wall Oscillation treatment with the AffloVest."

Weighing approximately 10 pounds, AffloVest is the lightest and most quiet device of its kind on the market today. Unlike other respiratory vest options, AffloVest provides adjustable levels of treatment intensity and multiple treatment modes. Doctors and patients can tailor their treatments to their needs, with settings that provide chest wall oscillation treatment on both the front and back of the vest.

The number of patients who can benefit from AffloVest is significant; for example, more than 10 million people in the United States currently live with COPD, according to the Centers for Disease Control.

AffloVest is available for Medicare and private health insurance reimbursement under the following Healthcare Common Procedure Coding System (HCPCS) code:

E0483 High Frequency Chest Wall Oscillation AffloVest is now available in five sizes – XS, S, M, L, XL – to serve both children and adults with chronic lung conditions.

AffloVest requires a physician's prescription and is available to U.S. patients through Durable Medical Equipment (DME) and Home Medical Equipment (HME) retailers.

About International Biophysics CorporationInternational Biophysics Corporation (IBC) is a privately held company that develops, manufactures, and sells a variety of complex medical devices. IBC's design and development capabilities include: CAD drawings/CAD interface, prototype development, initial product testing, tooling, mold design and manufacture, validation testing, and FDA submission. IBC is an ISO 13485 certified manufacturing company registered with the FDA, and is based in Austin, Texas. The distribution arm of IBC sells equipment and supplies ranging from centrifugal heart pumps, aortic punches, and blood suctioning wands. Its research and development team has also been involved in Portable Oxygen Concentrator development, dermatological laser devices, and other projects in various medical industries.Related Links:

www.AffloVest.comwww.biophysicscorp.com 

Media Contact:

Lisa Lawrencellawrence@salaspr.com512-426-4904


'/>"/>
SOURCE International Biophysics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Surveyed U.S. Neurologists Are More Likely Than Payers to Consider Biogen Idecs Tecfidera to be a Breakthrough in the Treatment of Multiple Sclerosis
2. World Molecular Imaging Congress to Feature Scientific Breakthroughs in Molecular Multimodal Imaging Essential to Precision Medicine
3. Online Nominations for 2014 Breakthrough Prizes in Life Sciences are Open
4. Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
5. Facebook and Twitter Drive Frenzy for Breakthrough "Anti-Aging Pill"
6. Tisch MS Researchers Announce Breakthrough in Disease Monitoring
7. HemoShear Co-Founder Presents Recommendations for Funding of Breakthrough Technologies to U.S. House of Representatives Committee on Science, Engineering and Technology
8. AlignMeds Breakthrough Garment Technology Gets a YES from the FDA!
9. Orthocare Innovations Once Again Recognized for Top Honors for its Breakthrough Prosthetic Foot Ankle System
10. New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
11. Zydus Pioneers a Breakthrough With LIPAGLYN, Indias First NCE to Reach the Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... EDMONTON, Alberta , July 21, 2017 ... the University of Alberta in Edmonton, ... Nature,s partner journal, Schizophrenia 1 , demonstrating that ... of schizophrenia with 74% accuracy. This retrospective analysis ... specific symptoms in schizophrenia patients with significant correlation, ...
(Date:7/20/2017)... PAUL, Minn. , July 20, 2017  Prime Therapeutics ... Jonathan Gavras , M.D., following today,s Institute for Clinical ... report on the effectiveness and value of abuse-deterrent ... manager on the policy roundtable at the meeting. ... is not a material cost benefit to the use of ...
(Date:7/14/2017)... , July 14, 2017 Endo International plc (NASDAQ: ... Tuesday, August 8, 2017.  Members of its senior management team will ... open at 8:30 a.m. ET. The dial-in number ... 497-0462, International (678) 509-7598, and the passcode is 45397076. Please dial ... A replay of the call will ...
Breaking Medicine Technology:
(Date:7/27/2017)... New York, NY (PRWEB) , ... July 27, ... ... Coordinator to President Barack Obama from 2012-2016, will keynote Day 2 of the ... security. The event kicks off at the Sheraton Boston Hotel, Sept. 11-13, 2017. ...
(Date:7/26/2017)... ... ... Capillus, LLC has announced the redesign of their FDA-cleared low-level laser (light) therapy ... more comfortable, adaptable fit and is available for purchase immediately. , Carlos Piña, ... caps intended to improve both user experience and hair regrowth. , “Our customers ...
(Date:7/26/2017)... ... July 26, 2017 , ... Six greater Bay Area roller derby leagues are partnering with Brown ... most widely attended series of blood drives in California, beginning July 29. Make ‘Em Bleed ... 4 years -- enough to have helped to save up to 2700 lives. , “The ...
(Date:7/26/2017)... ... July 26, 2017 , ... A major challenge many labs ... freeze drying samples and a lengthy freeze dry cycle are a few common challenges ... drying techniques, as well as new accessories and advancements in laboratory freeze dryers that ...
(Date:7/26/2017)... PITTSBURGH, PA (PRWEB) , ... July 26, 2017 , ... ... braces,” said Dr. Ahmed Mauassra, from San Jose, Calif., “so we invented the MAGNETIC/ ... remove the bracket portion of orthodontic braces. In doing so, it offers an effective ...
Breaking Medicine News(10 mins):